ketamine IV
Selected indexed studies
- Efficacy of intravenous ketamine and intranasal esketamine with dose escalation for Major depression: A systematic review and meta-analysis. (J Affect Disord, 2024) [PMID:38537759]
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). (Mol Psychiatry, 2020) [PMID:30283029]
- Adjunctive Ketamine With Relapse Prevention-Based Psychological Therapy in the Treatment of Alcohol Use Disorder. (Am J Psychiatry, 2022) [PMID:35012326]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy. (2019) pubmed
- Efficacy of intravenous ketamine and intranasal esketamine with dose escalation for Major depression: A systematic review and meta-analysis. (2024) pubmed
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). (2020) pubmed
- Adjunctive Ketamine With Relapse Prevention-Based Psychological Therapy in the Treatment of Alcohol Use Disorder. (2022) pubmed
- The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L'humeur Et De L'anxiété (Canmat) Concernant L'utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif Majeur. (2021) pubmed
- Ketamine and Esketamine in Clinical Trials: FDA-Approved and Emerging Indications, Trial Trends With Putative Mechanistic Explanations. (2025) pubmed
- Cognitive changes in patients with unipolar TRD treated with IV ketamine: A systematic review. (2024) pubmed
- Efficacy of ketamine for initial control of acute agitation in the emergency department: A randomized study. (2021) pubmed
- Intravenous (IV) ketamine versus intranasal esketamine for depression- Advantage IV ketamine? (2024) pubmed
- Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical Trial. (2025) pubmed